|
DESIGN OF A UNIVERSAL INFLUENZA VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
DESIGN OF A UNIVERSAL INFLUENZA VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
Researchers at Stanford have developed a novel universal influenza vaccine candidate.
Vaccines are a major feat of biomedical innovation. Successful vaccines produce broad humoral immunity to a pathogen to prevent subsequent infection. In this vein, adjuvants are compounds...
Published: 12/5/2023
|
Inventor(s): Duo Xu, Peter Kim
Keywords(s): Adjuvant, Alum, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|
|
IMMUNOGENIC EBOLAVIRUS FUSION PROTEINS AND RELATED METHODS
IMMUNOGENIC EBOLAVIRUS FUSION PROTEINS AND RELATED METHODS
Researchers at Stanford have developed a novel vaccine strategy for ebolavirus using fusion proteins composed of the virus’ glycoprotein.
Hemorrhagic fevers have become a major public health issue in Africa, the most notable of which being Ebola. Ebola has a notably high mortality...
Published: 10/6/2023
|
Inventor(s): Peter Kim, Duo Xu, Abigail Powell
Keywords(s): Ebola Virus, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|
|
TESTING DEVICES
TESTING DEVICES
Researchers at UCSF have developed new methods and a device for at home disease testing.
At home testing for SARS-CoV2 using lateral flow technology has been integral to pandemic containment efforts across the globe. Lateral flow diagnostics in general are widely available in point-of-care settings, such as for viral or bacterial...
Published: 1/31/2025
|
Inventor(s): Adam Abate, Charles Chiu, Krzysztof Langer, Daniel Weisgerber
Keywords(s): Diagnostics, Infectious Disease, LAMP, Lateral Flow Assay, PCR, Point-of-Care
Category(s): Technology Classifications > Biology
|
